Teranishi Hitoshi, Muneoka Yojiro, Takao Toshifumi, Shimonishi Yasutsugu, Kojima Masayasu
Molecular Genetics, Institute of Life Science, Kurume University, Kurume, Fukuoka 839-0861, Japan.
Regul Pept. 2004 Dec 15;123(1-3):173-9. doi: 10.1016/j.regpep.2004.04.024.
Four novel bioactive peptides were isolated from the red-bellied newt, Cynops pyrrhogaster, using a bioassay system monitoring the rectum contraction of the Japanese quail, Coturnix japonica. As these peptides are structurally related to vasoactive intestinal polypeptide (VIP), we termed these peptides newt VIP-related peptides 1, 2, 3, and 4 (NVRP-1, -2, -3, and -4). The primary sequences of these peptides were determined to be HSDAVFTDNYSRLLGKTALKNYLDGALKKE (NVRP-1), HSDAVFTDNYSRLLAKTALKNYLDGALKKE (NVRP-2), HSDAVFT-DNYSRLLGKIALKNYLDEALKKE (NVRP-3), and HSDAVFTDNYSRLLGKT-ALKNYLDSALKKE (NVRP-4). The N-terminal regions of these NVRPs possessed homology at the amino-acid level to various VIP, while the NVRP C-termini differed from VIPs significantly. All of the VIP consist of 28 amino-acid residues with amidated forms at the C-termini, whereas NVRPs possess 30 amino-acid residues and have free forms at the C-termini. NVRPs exert relaxant activities on isolated quail rectums in a dose-dependent manner, with threshold concentrations between 1 x 10(-8) and 3 x 10(-8) M. NVRPs also exhibited potent relaxant activities acting on the newt duodenum at 3 x 10(-8) M. As yet, this is the first isolation of biologically active VIP-related peptides from urodele.
利用监测日本鹌鹑(Coturnix japonica)直肠收缩的生物测定系统,从红腹蝾螈(Cynops pyrrhogaster)中分离出四种新型生物活性肽。由于这些肽在结构上与血管活性肠肽(VIP)相关,我们将这些肽命名为蝾螈VIP相关肽1、2、3和4(NVRP-1、-2、-3和-4)。这些肽的一级序列被确定为HSDAVFTDNYSRLLGKTALKNYLDGALKKE(NVRP-1)、HSDAVFTDNYSRLLAKTALKNYLDGALKKE(NVRP-2)、HSDAVFT-DNYSRLLGKIALKNYLDEALKKE(NVRP-3)和HSDAVFTDNYSRLLGKT-ALKNYLDSALKKE(NVRP-4)。这些NVRP的N端区域在氨基酸水平上与各种VIP具有同源性,而NVRP的C端与VIP有显著差异。所有的VIP由28个氨基酸残基组成,C端为酰胺化形式,而NVRP含有30个氨基酸残基,C端为游离形式。NVRP以剂量依赖的方式对分离的鹌鹑直肠发挥舒张活性,阈值浓度在1×10⁻⁸至3×10⁻⁸ M之间。NVRP在3×10⁻⁸ M时对蝾螈十二指肠也表现出强效的舒张活性。迄今为止,这是首次从有尾目动物中分离出具有生物活性的VIP相关肽。